Last 12 months
Inside the activity.
0 purchase rows · 1 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 1 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 16, 2020 Filed Jun 18, 2020 21:05 UTC |
Manning Anthony M.Director
|
GrantStock Option (right to buy) · Derivative | 127,000 | $0.00 Strike: $0.58 | $0.00 |
DisclosureSEC source: 0001654954-20-006796 · section16.xml · derivative · entry 2 Manning Anthony M. · CIK 0001716468 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 127,000 Underlying: Common Stock · 127,000 shares Expires 2030-06-16 F2 · derivative.exercise_date: The options vest at the rate of 1/12 per month on the last day of each month, starting on July 31, 2020. Read SEC document |
| June 16, 2020 Filed Jun 18, 2020 21:05 UTC |
Manning Anthony M.Director
|
GrantCommon Stock | 73,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001654954-20-006796 · section16.xml · nonDerivative · entry 1 Manning Anthony M. · CIK 0001716468 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 224,583 F1 · shares: Restricted share units granted under the 2011 Stock Incentive Plan, each of which represents the right to receive, without further payment, one share of common stock. The restricted share units vest on June 16, 2021. F1 · price: Restricted share units granted under the 2011 Stock Incentive Plan, each of which represents the right to receive, without further payment, one share of common stock. The restricted share units vest on June 16, 2021. Read SEC document |
| June 16, 2020 Filed Jun 18, 2020 21:02 UTC |
DUNTON ALAN WDirector
|
GrantStock option (right to buy) · Derivative | 127,000 | $0.00 Strike: $0.58 | $0.00 |
DisclosureSEC source: 0001654954-20-006793 · section16.xml · derivative · entry 2 DUNTON ALAN W · CIK 0001304773 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 127,000 Underlying: Common Stock · 127,000 shares Expires 2030-06-16 F2 · derivative.exercise_date: The options vest at the rate of 1/12 per month on the last day of each month, starting on July 31, 2020. Read SEC document |
| June 16, 2020 Filed Jun 18, 2020 21:02 UTC |
DUNTON ALAN WDirector
|
GrantCommon Stock | 73,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001654954-20-006793 · section16.xml · nonDerivative · entry 1 DUNTON ALAN W · CIK 0001304773 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 578,935 F1 · shares: Restricted share units granted under the 2011 Stock Incentive Plan, each of which represents the right to receive, without further payment, one share of common stock. The restricted share units vest on June 16, 2021. F1 · price: Restricted share units granted under the 2011 Stock Incentive Plan, each of which represents the right to receive, without further payment, one share of common stock. The restricted share units vest on June 16, 2021. Read SEC document |
| June 16, 2020 Filed Jun 18, 2020 21:02 UTC |
WILLS STEPHEN TExecutive VP and CFO/COO
|
GrantStock Option (right to buy) · Derivative | 461,500 | $0.00 Strike: $0.58 | $0.00 |
DisclosureSEC source: 0001654954-20-006792 · section16.xml · derivative · entry 2 WILLS STEPHEN T · CIK 0001103883 · Executive VP and CFO/COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 461,500 Underlying: Common Stock · 461,500 shares Expires 2030-06-16 F2 · derivative.exercise_date: The options vest at the rate of 25% per year, starting on June 16, 2021. Read SEC document |
| June 16, 2020 Filed Jun 18, 2020 21:02 UTC |
WILLS STEPHEN TExecutive VP and CFO/COO
|
GrantCommon Stock | 278,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001654954-20-006792 · section16.xml · nonDerivative · entry 1 WILLS STEPHEN T · CIK 0001103883 · Executive VP and CFO/COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,291,489 F1 · shares: Restricted share units granted under the 2011 Stock Incentive Plan, each of which represents the right to receive, without further payment, one share of common stock. The restricted share units vest at the rate of 25% per year, starting on June 16, 2021. F1 · price: Restricted share units granted under the 2011 Stock Incentive Plan, each of which represents the right to receive, without further payment, one share of common stock. The restricted share units vest at the rate of 25% per year, starting on June 16, 2021. Read SEC document |
| June 16, 2020 Filed Jun 18, 2020 21:02 UTC |
Rossetti AngelaDirector
|
GrantStock Option (Right to Buy) · Derivative | 127,000 | $0.00 Strike: $0.58 | $0.00 |
DisclosureSEC source: 0001654954-20-006791 · section16.xml · derivative · entry 2 Rossetti Angela · CIK 0001580657 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 127,000 Underlying: Common Stock · 127,000 shares Expires 2030-06-16 F2 · derivative.exercise_date: The options vest at the rate of 1/12 per month on the last day of each month, starting on July 31, 2020. Read SEC document |
| June 16, 2020 Filed Jun 18, 2020 21:02 UTC |
Rossetti AngelaDirector
|
GrantCommon Stock | 73,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001654954-20-006791 · section16.xml · nonDerivative · entry 1 Rossetti Angela · CIK 0001580657 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 503,585 F1 · shares: Restricted share units granted under the 2011 Stock Incentive Plan, each of which represents the right to receive, without further payment, one share of common stock. The restricted share units vest on June 16, 2021. F1 · price: Restricted share units granted under the 2011 Stock Incentive Plan, each of which represents the right to receive, without further payment, one share of common stock. The restricted share units vest on June 16, 2021. Read SEC document |
| June 16, 2020 Filed Jun 18, 2020 21:01 UTC |
DEVEER ROBERT K JRDirector
|
GrantStock Option (Right to Buy) · Derivative | 127,000 | $0.00 Strike: $0.58 | $0.00 |
DisclosureSEC source: 0001654954-20-006783 · section16.xml · derivative · entry 2 DEVEER ROBERT K JR · CIK 0001158829 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 127,000 Underlying: Common Stock · 127,000 shares Expires 2030-06-16 F2 · derivative.exercise_date: The options vest at the rate of 1/12 per month on the last day of each month, starting on July 31, 2020. Read SEC document |
| June 16, 2020 Filed Jun 18, 2020 21:01 UTC |
DEVEER ROBERT K JRDirector
|
GrantCommon Stock | 73,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001654954-20-006783 · section16.xml · nonDerivative · entry 1 DEVEER ROBERT K JR · CIK 0001158829 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 669,723 F1 · shares: Restricted share units granted under the 2011 Stock Incentive Plan, each of which represents the right to receive, without further payment, one share of common stock. The restricted share units vest on June 16, 2021. F1 · price: Restricted share units granted under the 2011 Stock Incentive Plan, each of which represents the right to receive, without further payment, one share of common stock. The restricted share units vest on June 16, 2021. Read SEC document |
| June 16, 2020 Filed Jun 18, 2020 21:01 UTC |
Hull Joseph StanleyDirector
|
GrantStock Option (Right to Buy) · Derivative | 127,000 | $0.00 Strike: $0.58 | $0.00 |
DisclosureSEC source: 0001654954-20-006785 · section16.xml · derivative · entry 2 Hull Joseph Stanley · CIK 0001338384 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 127,000 Underlying: Common Stock · 127,000 shares Expires 2030-06-16 F2 · derivative.exercise_date: The options vest at the rate of 1/12 per month on the last day of each month, starting on July 31, 2020. Read SEC document |
| June 16, 2020 Filed Jun 18, 2020 21:01 UTC |
Hull Joseph StanleyDirector
|
GrantCommon Stock | 73,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001654954-20-006785 · section16.xml · nonDerivative · entry 1 Hull Joseph Stanley · CIK 0001338384 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 622,383 F1 · shares: Restricted share units granted under the 2011 Stock Incentive Plan, each of which represents the right to receive, without further payment, one share of common stock. The restricted share units vest on June 16, 2021. F1 · price: Restricted share units granted under the 2011 Stock Incentive Plan, each of which represents the right to receive, without further payment, one share of common stock. The restricted share units vest on June 16, 2021. Read SEC document |
| June 16, 2020 Filed Jun 18, 2020 21:01 UTC |
Morris ArleneDirector
|
GrantStock Option (Right to Buy) · Derivative | 127,000 | $0.00 Strike: $0.58 | $0.00 |
DisclosureSEC source: 0001654954-20-006787 · section16.xml · derivative · entry 2 Morris Arlene · CIK 0001362520 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 127,000 Underlying: Common Stock · 127,000 shares Expires 2030-06-16 F2 · derivative.exercise_date: The options vest at the rate of 1/12 per month on the last day of each month, starting on July 31, 2020. Read SEC document |
| June 16, 2020 Filed Jun 18, 2020 21:01 UTC |
Morris ArleneDirector
|
GrantCommon Stock | 73,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001654954-20-006787 · section16.xml · nonDerivative · entry 1 Morris Arlene · CIK 0001362520 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 445,583 F1 · shares: Restricted share units granted under the 2011 Stock Incentive Plan, each of which represents the right to receive, without further payment, one share of common stock. The restricted share units vest on June 16, 2021. F1 · price: Restricted share units granted under the 2011 Stock Incentive Plan, each of which represents the right to receive, without further payment, one share of common stock. The restricted share units vest on June 16, 2021. Read SEC document |
| June 16, 2020 Filed Jun 18, 2020 21:00 UTC |
SPANA CARLDirector · President and CEO
|
GrantStock Option (Right to Buy) · Derivative | 535,750 | $0.00 Strike: $0.58 | $0.00 |
DisclosureSEC source: 0001654954-20-006782 · section16.xml · derivative · entry 2 SPANA CARL · CIK 0001042011 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 535,750 Underlying: Common Stock · 535,750 shares Expires 2030-06-16 F2 · derivative.exercise_date: Options vest at the rate of 25% per year, starting on June 16, 2021. Read SEC document |
| June 16, 2020 Filed Jun 18, 2020 21:00 UTC |
SPANA CARLDirector · President and CEO
|
GrantCommon Stock | 323,250 | $0.00 | $0.00 |
DisclosureSEC source: 0001654954-20-006782 · section16.xml · nonDerivative · entry 1 SPANA CARL · CIK 0001042011 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,097,102 F1 · shares: Restricted share units granted under the 2011 Stock Incentive Plan, each of which represents the right to receive, without further payment, one share of common stock. The restricted share units vest at the rate of 25% per year, starting on June 16, 2021. F1 · price: Restricted share units granted under the 2011 Stock Incentive Plan, each of which represents the right to receive, without further payment, one share of common stock. The restricted share units vest at the rate of 25% per year, starting on June 16, 2021. Read SEC document |
| August 05, 2019 Filed Aug 7, 2019 20:30 UTC |
Hull Joseph StanleyDirector
|
PurchaseCommon Stock | 800 | $0.78 | $627.44 |
DisclosureSEC source: 0001654954-19-008981 · section16.xml · nonDerivative · entry 1 Hull Joseph Stanley · CIK 0001338384 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 520,799 Read SEC document |
| August 02, 2019 Filed Aug 5, 2019 20:12 UTC |
SPANA CARLDirector · President and CEO
|
PurchaseCommon Stock | 20,000 | $0.86 | $17,260.00 |
DisclosureSEC source: 0001654954-19-008834 · section16.xml · nonDerivative · entry 3 SPANA CARL · CIK 0001042011 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,993,852 Read SEC document |
| August 01, 2019 Filed Aug 5, 2019 20:12 UTC |
SPANA CARLDirector · President and CEO
|
PurchaseCommon Stock | 20,000 | $0.86 | $17,260.00 |
DisclosureSEC source: 0001654954-19-008834 · section16.xml · nonDerivative · entry 2 SPANA CARL · CIK 0001042011 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,973,852 Read SEC document |
| August 01, 2019 Filed Aug 5, 2019 20:12 UTC |
SPANA CARLDirector · President and CEO
|
PurchaseCommon Stock | 10,000 | $0.86 | $8,599.00 |
DisclosureSEC source: 0001654954-19-008834 · section16.xml · nonDerivative · entry 1 SPANA CARL · CIK 0001042011 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,953,852 Read SEC document |
| August 01, 2019 Filed Aug 5, 2019 20:18 UTC |
WILLS STEPHEN TExecutive VP and CFO/COO
|
PurchaseCommon Stock | 50,000 | $0.87 | $43,250.00 |
DisclosureSEC source: 0001654954-19-008840 · section16.xml · nonDerivative · entry 1 WILLS STEPHEN T · CIK 0001103883 · Executive VP and CFO/COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,314,239 F1 · price: Weighted average of price paid per share on order. The reporting person hereby undertakes upon request to provide to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| August 01, 2019 Filed Aug 5, 2019 20:14 UTC |
DEVEER ROBERT K JRDirector
|
PurchaseCommon Stock | 22,580 | $0.86 | $19,418.80 |
DisclosureSEC source: 0001654954-19-008837 · section16.xml · nonDerivative · entry 1 DEVEER ROBERT K JR · CIK 0001158829 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 568,139 Read SEC document |
| June 24, 2019 Filed Jun 26, 2019 20:38 UTC |
PRENDERGAST JOHN K ADirector
|
GrantStock Option (right to buy) · Derivative | 70,000 | $0.00 Strike: $1.34 | $0.00 |
DisclosureSEC source: 0001654954-19-007692 · section16.xml · derivative · entry 2 PRENDERGAST JOHN K A · CIK 0001042019 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,000 Underlying: Common Stock · 70,000 shares Expires 2029-06-24 F2 · derivative.exercise_date: The options vest at the rate of 1/12 per month on the last day of each month, starting on July 31, 2019. Read SEC document |
| June 24, 2019 Filed Jun 26, 2019 20:38 UTC |
PRENDERGAST JOHN K ADirector
|
GrantCommon Stock | 84,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001654954-19-007692 · section16.xml · nonDerivative · entry 1 PRENDERGAST JOHN K A · CIK 0001042019 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 968,850 F1 · shares: Restricted share units granted under the 2011 Stock Incentive Plan, each of which represents the right to receive, without further payment, one share of common stock. The restricted share units vest on June 24, 2020. F1 · price: Restricted share units granted under the 2011 Stock Incentive Plan, each of which represents the right to receive, without further payment, one share of common stock. The restricted share units vest on June 24, 2020. Read SEC document |
| June 24, 2019 Filed Jun 26, 2019 20:38 UTC |
Manning Anthony M.Director
|
GrantStock Option (right to buy) · Derivative | 52,000 | $0.00 Strike: $1.34 | $0.00 |
DisclosureSEC source: 0001654954-19-007691 · section16.xml · derivative · entry 2 Manning Anthony M. · CIK 0001716468 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,000 Underlying: Common Stock · 52,000 shares Expires 2029-06-24 F2 · derivative.exercise_date: The options vest at the rate of 1/12 per month on the last day of each month, starting on July 31, 2019. Read SEC document |
| June 24, 2019 Filed Jun 26, 2019 20:38 UTC |
Manning Anthony M.Director
|
GrantCommon Stock | 32,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001654954-19-007691 · section16.xml · nonDerivative · entry 1 Manning Anthony M. · CIK 0001716468 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 97,333 F1 · shares: Restricted share units granted under the 2011 Stock Incentive Plan, each of which represents the right to receive, without further payment, one share of common stock. The restricted share units vest on June 24, 2020. F1 · price: Restricted share units granted under the 2011 Stock Incentive Plan, each of which represents the right to receive, without further payment, one share of common stock. The restricted share units vest on June 24, 2020. Read SEC document |
| June 24, 2019 Filed Jun 26, 2019 20:38 UTC |
Morris ArleneDirector
|
GrantStock Option (right to buy) · Derivative | 52,000 | $0.00 Strike: $1.34 | $0.00 |
DisclosureSEC source: 0001654954-19-007690 · section16.xml · derivative · entry 2 Morris Arlene · CIK 0001362520 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,000 Underlying: Common Stock · 52,000 shares Expires 2029-06-24 F2 · derivative.exercise_date: The options vest at the rate of 1/12 per month on the last day of each month, starting on July 31, 2019. Read SEC document |
| June 24, 2019 Filed Jun 26, 2019 20:38 UTC |
Morris ArleneDirector
|
GrantCommon Stock | 32,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001654954-19-007690 · section16.xml · nonDerivative · entry 1 Morris Arlene · CIK 0001362520 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 335,333 F1 · shares: Restricted share units granted under the 2011 Stock Incentive Plan, each of which represents the right to receive, without further payment, one share of common stock. The restricted share units vest on June 24, 2020. F1 · price: Restricted share units granted under the 2011 Stock Incentive Plan, each of which represents the right to receive, without further payment, one share of common stock. The restricted share units vest on June 24, 2020. Read SEC document |
| June 24, 2019 Filed Jun 26, 2019 20:38 UTC |
WILLS STEPHEN TExecutive VP and CFO/COO
|
GrantStock Option (right to buy) · Derivative | 237,500 | $0.00 Strike: $0.85 | $0.00 |
DisclosureSEC source: 0001654954-19-007685 · section16.xml · derivative · entry 4 WILLS STEPHEN T · CIK 0001103883 · Executive VP and CFO/COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 237,500 Underlying: Common Stock · 237,500 shares Expires 2027-12-12 F4 · derivative.exercise_date: Vesting of performance condition stock option grant, made December 12, 2017, which vested in part on June 24, 2019, upon certification by the Compensation Committee that a defined performance objection as to 50% of the target number of share units had been achieved, the approval by the U.S. Food and Drug Administration of a New Drug Application for bremelanotide for hypoactive sexual desire disorder in premenopausal woemen during the defined performance period. Read SEC document |
| June 24, 2019 Filed Jun 26, 2019 20:38 UTC |
WILLS STEPHEN TExecutive VP and CFO/COO
|
GrantStock Option (right to buy) · Derivative | 638,000 | $0.00 Strike: $1.34 | $0.00 |
DisclosureSEC source: 0001654954-19-007685 · section16.xml · derivative · entry 3 WILLS STEPHEN T · CIK 0001103883 · Executive VP and CFO/COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 638,000 Underlying: Common Stock · 638,000 shares Expires 2029-06-24 F3 · derivative.exercise_date: Options vest at the rate of 25% per year, starting on June 24, 2020. Read SEC document |
| June 24, 2019 Filed Jun 26, 2019 20:38 UTC |
WILLS STEPHEN TExecutive VP and CFO/COO
|
GrantCommon Stock | 202,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001654954-19-007685 · section16.xml · nonDerivative · entry 2 WILLS STEPHEN T · CIK 0001103883 · Executive VP and CFO/COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,212,989 F2 · shares: Restricted share units granted under the 2011 Stock Incentive Plan, each of which represents the right to receive, without further payment, one share of common stock. The restricted share units vest at the rate of 25% per year, starting on June 24, 2020. F2 · price: Restricted share units granted under the 2011 Stock Incentive Plan, each of which represents the right to receive, without further payment, one share of common stock. The restricted share units vest at the rate of 25% per year, starting on June 24, 2020. Read SEC document |
| June 24, 2019 Filed Jun 26, 2019 20:38 UTC |
WILLS STEPHEN TExecutive VP and CFO/COO
|
GrantCommon Stock | 237,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001654954-19-007685 · section16.xml · nonDerivative · entry 1 WILLS STEPHEN T · CIK 0001103883 · Executive VP and CFO/COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,010,989 F1 · shares: Restricted share units granted under the 2011 Stock Incentive Plan, each of which represents the right to receive, without further payment, one share of common stock. The performance condition grant, made December 12, 2017, vested in part on June 24, 2019 upon certification by the Compensation Committee that a defined performance objective as to 50% of the target number of share units had been achieved, the approval by the U.S. Food and Drug Administration of a New Drug Application for bremelanotide for hypoactive sexual desire disorder in premenopausal women during the defined performance period. Vested shares, subject to the terms of the applicable restricted share unit agreement, will be delivered following the reporting person ceasing to serve as an employee of Palatin Technologies, Inc. F1 · price: Restricted share units granted under the 2011 Stock Incentive Plan, each of which represents the right to receive, without further payment, one share of common stock. The performance condition grant, made December 12, 2017, vested in part on June 24, 2019 upon certification by the Compensation Committee that a defined performance objective as to 50% of the target number of share units had been achieved, the approval by the U.S. Food and Drug Administration of a New Drug Application for bremelanotide for hypoactive sexual desire disorder in premenopausal women during the defined performance period. Vested shares, subject to the terms of the applicable restricted share unit agreement, will be delivered following the reporting person ceasing to serve as an employee of Palatin Technologies, Inc. Read SEC document |
| June 24, 2019 Filed Jun 26, 2019 20:38 UTC |
Rossetti AngelaDirector
|
GrantStock Option (right to buy) · Derivative | 52,000 | $0.00 Strike: $1.34 | $0.00 |
DisclosureSEC source: 0001654954-19-007689 · section16.xml · derivative · entry 2 Rossetti Angela · CIK 0001580657 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,000 Underlying: Common Stock · 52,000 shares Expires 2029-06-24 F2 · derivative.exercise_date: The options vest at the rate of 1/12 per month on the last day of each month, starting on July 31, 2019. Read SEC document |
| June 24, 2019 Filed Jun 26, 2019 20:38 UTC |
Rossetti AngelaDirector
|
GrantCommon Stock | 32,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001654954-19-007689 · section16.xml · nonDerivative · entry 1 Rossetti Angela · CIK 0001580657 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 393,333 F1 · shares: Restricted share units granted under the 2011 Stock Incentive Plan, each of which represents the right to receive, without further payment, one share of common stock. The restricted share units vest on June 24, 2020. F1 · price: Restricted share units granted under the 2011 Stock Incentive Plan, each of which represents the right to receive, without further payment, one share of common stock. The restricted share units vest on June 24, 2020. Read SEC document |
| June 24, 2019 Filed Jun 26, 2019 20:38 UTC |
Hull Joseph StanleyDirector
|
GrantStock Option (right to buy) · Derivative | 52,000 | $0.00 Strike: $1.34 | $0.00 |
DisclosureSEC source: 0001654954-19-007688 · section16.xml · derivative · entry 2 Hull Joseph Stanley · CIK 0001338384 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,000 Underlying: Common Stock · 52,000 shares Expires 2029-06-24 F2 · derivative.exercise_date: The options vest at the rate of 1/12 per month on the last day of each month, starting on July 31, 2019. Read SEC document |
| June 24, 2019 Filed Jun 26, 2019 20:38 UTC |
Hull Joseph StanleyDirector
|
GrantCommon Stock | 32,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001654954-19-007688 · section16.xml · nonDerivative · entry 1 Hull Joseph Stanley · CIK 0001338384 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 515,333 F1 · shares: Restricted share units granted under the 2011 Stock Incentive Plan, each of which represents the right to receive, without further payment, one share of common stock. The restricted share units vest on June 24, 2020. F1 · price: Restricted share units granted under the 2011 Stock Incentive Plan, each of which represents the right to receive, without further payment, one share of common stock. The restricted share units vest on June 24, 2020. Read SEC document |
| June 24, 2019 Filed Jun 26, 2019 20:38 UTC |
DEVEER ROBERT K JRDirector
|
GrantStock Option (right to buy) · Derivative | 52,000 | $0.00 Strike: $1.34 | $0.00 |
DisclosureSEC source: 0001654954-19-007687 · section16.xml · derivative · entry 2 DEVEER ROBERT K JR · CIK 0001158829 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,000 Underlying: Commom Stock · 52,000 shares Expires 2029-06-24 F2 · derivative.exercise_date: The options vest at the rate of 1/12 per month on the last day of each month, starting on July 31, 2019. Read SEC document |
| June 24, 2019 Filed Jun 26, 2019 20:38 UTC |
DEVEER ROBERT K JRDirector
|
GrantCommon Stock | 32,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001654954-19-007687 · section16.xml · nonDerivative · entry 1 DEVEER ROBERT K JR · CIK 0001158829 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 544,393 F1 · shares: Restricted share units granted under the 2011 Stock Incentive Plan, each of which represents the right to receive, without further payment, one share of common stock. The restricted share units vest on June 24, 2020. F1 · price: Restricted share units granted under the 2011 Stock Incentive Plan, each of which represents the right to receive, without further payment, one share of common stock. The restricted share units vest on June 24, 2020. Read SEC document |
| June 24, 2019 Filed Jun 26, 2019 20:38 UTC |
DUNTON ALAN WDirector
|
GrantStock Option (right to buy) · Derivative | 52,000 | $0.00 Strike: $1.34 | $0.00 |
DisclosureSEC source: 0001654954-19-007686 · section16.xml · derivative · entry 2 DUNTON ALAN W · CIK 0001304773 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,000 Underlying: Common Stock · 52,000 shares Expires 2029-06-24 F2 · derivative.exercise_date: The options vest at the rate of 1/12 per month on the last day of each month, starting on July 31, 2019. Read SEC document |
| June 24, 2019 Filed Jun 26, 2019 20:38 UTC |
DUNTON ALAN WDirector
|
GrantCommon Stock | 32,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001654954-19-007686 · section16.xml · nonDerivative · entry 1 DUNTON ALAN W · CIK 0001304773 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 468,685 F1 · shares: Restricted share units granted under the 2011 Stock Incentive Plan, each of which represents the right to receive, without further payment, one share of common stock. The restricted share units vest on June 24, 2020. F1 · price: Restricted share units granted under the 2011 Stock Incentive Plan, each of which represents the right to receive, without further payment, one share of common stock. The restricted share units vest on June 24, 2020. Read SEC document |
| June 24, 2019 Filed Jun 26, 2019 20:38 UTC |
SPANA CARLDirector · President and CEO
|
GrantStock Option (right to buy) · Derivative | 312,500 | $0.00 Strike: $0.85 | $0.00 |
DisclosureSEC source: 0001654954-19-007684 · section16.xml · derivative · entry 4 SPANA CARL · CIK 0001042011 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 312,500 Underlying: Common Stock · 312,500 shares Expires 2027-12-12 F4 · derivative.exercise_date: Vesting of performance condition stock option grant, made December 12, 2017, which vested in part on June 24, 2019, upon certification by the Compensation Committee that a defined performance objection as to 50% of the target number of share units had been achieved, the approval by the U.S. Food and Drug Administration of a New Drug Application for bremelanotide for hypoactive sexual desire disorder in premenopausal woemen during the defined performance period. Read SEC document |
| June 24, 2019 Filed Jun 26, 2019 20:38 UTC |
SPANA CARLDirector · President and CEO
|
GrantStock Option (right to buy) · Derivative | 744,000 | $0.00 Strike: $1.34 | $0.00 |
DisclosureSEC source: 0001654954-19-007684 · section16.xml · derivative · entry 3 SPANA CARL · CIK 0001042011 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 744,000 Underlying: Common Stock · 744,000 shares Expires 2029-06-24 F3 · derivative.exercise_date: Options vest at the rate of 25% per year, starting on June 24, 2020. Read SEC document |
| June 24, 2019 Filed Jun 26, 2019 20:38 UTC |
SPANA CARLDirector · President and CEO
|
GrantCommon Stock | 236,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001654954-19-007684 · section16.xml · nonDerivative · entry 2 SPANA CARL · CIK 0001042011 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,891,352 F2 · shares: Restricted share units granted under the 2011 Stock Incentive Plan, each of which represents the right to receive, without further payment, one share of common stock. The restricted share units vest at the rate of 25% per year, starting on June 24, 2020. F2 · price: Restricted share units granted under the 2011 Stock Incentive Plan, each of which represents the right to receive, without further payment, one share of common stock. The restricted share units vest at the rate of 25% per year, starting on June 24, 2020. Read SEC document |
| June 24, 2019 Filed Jun 26, 2019 20:38 UTC |
SPANA CARLDirector · President and CEO
|
GrantCommon Stock | 312,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001654954-19-007684 · section16.xml · nonDerivative · entry 1 SPANA CARL · CIK 0001042011 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,655,352 F1 · shares: Restricted share units granted under the 2011 Stock Incentive Plan, each of which represents the right to receive, without further payment, one share of common stock. The performance condition grant, made December 12, 2017, vested in part on June 24, 2019 upon certification by the Compensation Committee that a defined performance objective as to 50% of the target number of share units had been achieved, the approval by the U.S. Food and Drug Administration of a New Drug Application for bremelanotide for hypoactive sexual desire disorder in premenopausal women during the defined performance period. Vested shares, subject to the terms of the applicable restricted share unit agreement, will be delivered following the reporting person ceasing to serve as an employee of Palatin Technologies, Inc. F1 · price: Restricted share units granted under the 2011 Stock Incentive Plan, each of which represents the right to receive, without further payment, one share of common stock. The performance condition grant, made December 12, 2017, vested in part on June 24, 2019 upon certification by the Compensation Committee that a defined performance objective as to 50% of the target number of share units had been achieved, the approval by the U.S. Food and Drug Administration of a New Drug Application for bremelanotide for hypoactive sexual desire disorder in premenopausal women during the defined performance period. Vested shares, subject to the terms of the applicable restricted share unit agreement, will be delivered following the reporting person ceasing to serve as an employee of Palatin Technologies, Inc. Read SEC document |
| November 20, 2018 Filed Nov 21, 2018 17:03 UTC |
Morris ArleneDirector
|
PurchaseCommon Stock | 100 | $0.69 | $68.78 |
DisclosureSEC source: 0001654954-18-013089 · section16.xml · nonDerivative · entry 5 Morris Arlene · CIK 0001362520 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 288,999 Read SEC document |
| November 20, 2018 Filed Nov 21, 2018 17:03 UTC |
Morris ArleneDirector
|
PurchaseCommon Stock | 2,100 | $0.69 | $1,439.55 |
DisclosureSEC source: 0001654954-18-013089 · section16.xml · nonDerivative · entry 4 Morris Arlene · CIK 0001362520 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 288,899 Read SEC document |
| November 20, 2018 Filed Nov 21, 2018 17:03 UTC |
Morris ArleneDirector
|
PurchaseCommon Stock | 100 | $0.69 | $68.54 |
DisclosureSEC source: 0001654954-18-013089 · section16.xml · nonDerivative · entry 3 Morris Arlene · CIK 0001362520 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 286,799 Read SEC document |
| November 20, 2018 Filed Nov 21, 2018 17:03 UTC |
Morris ArleneDirector
|
PurchaseCommon Stock | 100 | $0.69 | $68.53 |
DisclosureSEC source: 0001654954-18-013089 · section16.xml · nonDerivative · entry 2 Morris Arlene · CIK 0001362520 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 286,699 Read SEC document |
| November 20, 2018 Filed Nov 21, 2018 17:03 UTC |
Morris ArleneDirector
|
PurchaseCommon Stock | 9,600 | $0.69 | $6,577.92 |
DisclosureSEC source: 0001654954-18-013089 · section16.xml · nonDerivative · entry 1 Morris Arlene · CIK 0001362520 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 286,599 Read SEC document |
| November 16, 2018 Filed Nov 19, 2018 21:23 UTC |
SPANA CARLDirector · President and CEO
|
PurchaseCommon Stock | 20,000 | $0.79 | $15,766.00 |
DisclosureSEC source: 0001654954-18-012961 · section16.xml · nonDerivative · entry 1 SPANA CARL · CIK 0001042011 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,348,102 F1 · price: Weighted average of price paid per share on order. The reporting person hereby undertakes upon request to provide to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.